 | • レポートコード：MRC2-11QY11454 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はコンパニオン診断のグローバル市場について調査・分析したレポートです。種類別（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS））市場規模、用途別（病院、製薬会社、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別コンパニオン診断の競争状況、市場シェア ・世界のコンパニオン診断市場：種類別市場規模 2015年-2020年（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS）） ・世界のコンパニオン診断市場：種類別市場規模予測 2021年-2026年（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS）） ・世界のコンパニオン診断市場：用途別市場規模 2015年-2020年（病院、製薬会社、研究所、その他） ・世界のコンパニオン診断市場：用途別市場規模予測 2021年-2026年（病院、製薬会社、研究所、その他） ・北米のコンパニオン診断市場分析：米国、カナダ ・ヨーロッパのコンパニオン診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのコンパニオン診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のコンパニオン診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのコンパニオン診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Holdings、Abbott Laboratories、Thermo Fisher Scientific、Agilent Technologies、Life Technologies、GE Healthcare、Agendia、Qiagen、Genomic Health、Myriad Genetics、Advanced Cell Diagnostics、Danaher、Applied Proteomics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Companion Diagnostics Market
The global Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Companion Diagnostics Scope and Market Size
Companion Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market segment by Application, split into
Hospitals
Pharmaceutical Companies
Laboratories
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Companion Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Polymerase Chain Reaction (PCR)
1.4.3 Immunohistochemistry (IHC)
1.4.4 In Situ Hybridization (ISH)
1.4.5 Next Generation Sequencing (NGS)
1.5 Market by Application
1.5.1 Global Companion Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pharmaceutical Companies
1.5.4 Laboratories
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics Market Perspective (2015-2026)
2.2 Global Companion Diagnostics Growth Trends by Regions
2.2.1 Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Companion Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Companion Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Companion Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Companion Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics Players by Market Size
3.1.1 Global Top Companion Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Companion Diagnostics Market Concentration Ratio
3.2.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2019
3.3 Companion Diagnostics Key Players Head office and Area Served
3.4 Key Players Companion Diagnostics Product Solution and Service
3.5 Date of Enter into Companion Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Companion Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Companion Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Companion Diagnostics Market Size by Application (2015-2020)
5.2 Global Companion Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Companion Diagnostics Market Size (2015-2020)
6.2 Companion Diagnostics Key Players in North America (2019-2020)
6.3 North America Companion Diagnostics Market Size by Type (2015-2020)
6.4 North America Companion Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Companion Diagnostics Market Size (2015-2020)
7.2 Companion Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Companion Diagnostics Market Size by Type (2015-2020)
7.4 Europe Companion Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Companion Diagnostics Market Size (2015-2020)
8.2 Companion Diagnostics Key Players in China (2019-2020)
8.3 China Companion Diagnostics Market Size by Type (2015-2020)
8.4 China Companion Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Companion Diagnostics Market Size (2015-2020)
9.2 Companion Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Companion Diagnostics Market Size by Type (2015-2020)
9.4 Japan Companion Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Companion Diagnostics Market Size (2015-2020)
10.2 Companion Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Companion Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Companion Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Companion Diagnostics Market Size (2015-2020)
11.2 Companion Diagnostics Key Players in India (2019-2020)
11.3 India Companion Diagnostics Market Size by Type (2015-2020)
11.4 India Companion Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Companion Diagnostics Market Size (2015-2020)
12.2 Companion Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Companion Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Companion Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Holdings
13.1.1 Roche Holdings Company Details
13.1.2 Roche Holdings Business Overview
13.1.3 Roche Holdings Companion Diagnostics Introduction
13.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2015-2020))
13.1.5 Roche Holdings Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Companion Diagnostics Introduction
13.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview
13.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction
13.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 Agilent Technologies
13.4.1 Agilent Technologies Company Details
13.4.2 Agilent Technologies Business Overview
13.4.3 Agilent Technologies Companion Diagnostics Introduction
13.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020)
13.4.5 Agilent Technologies Recent Development
13.5 Life Technologies
13.5.1 Life Technologies Company Details
13.5.2 Life Technologies Business Overview
13.5.3 Life Technologies Companion Diagnostics Introduction
13.5.4 Life Technologies Revenue in Companion Diagnostics Business (2015-2020)
13.5.5 Life Technologies Recent Development
13.6 GE Healthcare
13.6.1 GE Healthcare Company Details
13.6.2 GE Healthcare Business Overview
13.6.3 GE Healthcare Companion Diagnostics Introduction
13.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2015-2020)
13.6.5 GE Healthcare Recent Development
13.7 Agendia
13.7.1 Agendia Company Details
13.7.2 Agendia Business Overview
13.7.3 Agendia Companion Diagnostics Introduction
13.7.4 Agendia Revenue in Companion Diagnostics Business (2015-2020)
13.7.5 Agendia Recent Development
13.8 Qiagen
13.8.1 Qiagen Company Details
13.8.2 Qiagen Business Overview
13.8.3 Qiagen Companion Diagnostics Introduction
13.8.4 Qiagen Revenue in Companion Diagnostics Business (2015-2020)
13.8.5 Qiagen Recent Development
13.9 Genomic Health
13.9.1 Genomic Health Company Details
13.9.2 Genomic Health Business Overview
13.9.3 Genomic Health Companion Diagnostics Introduction
13.9.4 Genomic Health Revenue in Companion Diagnostics Business (2015-2020)
13.9.5 Genomic Health Recent Development
13.10 Myriad Genetics
13.10.1 Myriad Genetics Company Details
13.10.2 Myriad Genetics Business Overview
13.10.3 Myriad Genetics Companion Diagnostics Introduction
13.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020)
13.10.5 Myriad Genetics Recent Development
13.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Company Details
10.11.2 Advanced Cell Diagnostics Business Overview
10.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction
10.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020)
10.11.5 Advanced Cell Diagnostics Recent Development
13.12 Danaher
10.12.1 Danaher Company Details
10.12.2 Danaher Business Overview
10.12.3 Danaher Companion Diagnostics Introduction
10.12.4 Danaher Revenue in Companion Diagnostics Business (2015-2020)
10.12.5 Danaher Recent Development
13.13 Applied Proteomics
10.13.1 Applied Proteomics Company Details
10.13.2 Applied Proteomics Business Overview
10.13.3 Applied Proteomics Companion Diagnostics Introduction
10.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020)
10.13.5 Applied Proteomics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Companion Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Companion Diagnostics Revenue
Table 3. Ranking of Global Top Companion Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Polymerase Chain Reaction (PCR)
Table 6. Key Players of Immunohistochemistry (IHC)
Table 7. Key Players of In Situ Hybridization (ISH)
Table 8. Key Players of Next Generation Sequencing (NGS)
Table 9. Global Companion Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Companion Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Companion Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Companion Diagnostics Market Share by Regions (2015-2020)
Table 13. Global Companion Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Companion Diagnostics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Companion Diagnostics Market Growth Strategy
Table 19. Main Points Interviewed from Key Companion Diagnostics Players
Table 20. Global Companion Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Companion Diagnostics Market Share by Players (2015-2020)
Table 22. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostics as of 2019)
Table 23. Global Companion Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Companion Diagnostics Product Solution and Service
Table 26. Date of Enter into Companion Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Companion Diagnostics Market Size Share by Type (2015-2020)
Table 30. Global Companion Diagnostics Revenue Market Share by Type (2021-2026)
Table 31. Global Companion Diagnostics Market Size Share by Application (2015-2020)
Table 32. Global Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Companion Diagnostics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Companion Diagnostics Market Share (2019-2020)
Table 36. North America Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Companion Diagnostics Market Share by Type (2015-2020)
Table 38. North America Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Companion Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Companion Diagnostics Market Share (2019-2020)
Table 42. Europe Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Companion Diagnostics Market Share by Type (2015-2020)
Table 44. Europe Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Companion Diagnostics Market Share by Application (2015-2020)
Table 46. China Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Companion Diagnostics Market Share (2019-2020)
Table 48. China Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 49. China Companion Diagnostics Market Share by Type (2015-2020)
Table 50. China Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 51. China Companion Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Companion Diagnostics Market Share (2019-2020)
Table 54. Japan Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Companion Diagnostics Market Share by Type (2015-2020)
Table 56. Japan Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Companion Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Companion Diagnostics Market Share (2019-2020)
Table 60. Southeast Asia Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Companion Diagnostics Market Share by Type (2015-2020)
Table 62. Southeast Asia Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Companion Diagnostics Market Share by Application (2015-2020)
Table 64. India Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Companion Diagnostics Market Share (2019-2020)
Table 66. India Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 67. India Companion Diagnostics Market Share by Type (2015-2020)
Table 68. India Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 69. India Companion Diagnostics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Companion Diagnostics Market Share (2019-2020)
Table 72. Central & South America Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Companion Diagnostics Market Share by Type (2015-2020)
Table 74. Central & South America Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Companion Diagnostics Market Share by Application (2015-2020)
Table 76. Roche Holdings Company Details
Table 77. Roche Holdings Business Overview
Table 78. Roche Holdings Product
Table 79. Roche Holdings Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 80. Roche Holdings Recent Development
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories Recent Development
Table 86. Thermo Fisher Scientific Company Details
Table 87. Thermo Fisher Scientific Business Overview
Table 88. Thermo Fisher Scientific Product
Table 89. Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 90. Thermo Fisher Scientific Recent Development
Table 91. Agilent Technologies Company Details
Table 92. Agilent Technologies Business Overview
Table 93. Agilent Technologies Product
Table 94. Agilent Technologies Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 95. Agilent Technologies Recent Development
Table 96. Life Technologies Company Details
Table 97. Life Technologies Business Overview
Table 98. Life Technologies Product
Table 99. Life Technologies Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 100. Life Technologies Recent Development
Table 101. GE Healthcare Company Details
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Product
Table 104. GE Healthcare Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 105. GE Healthcare Recent Development
Table 106. Agendia Company Details
Table 107. Agendia Business Overview
Table 108. Agendia Product
Table 109. Agendia Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 110. Agendia Recent Development
Table 111. Qiagen Business Overview
Table 112. Qiagen Product
Table 113. Qiagen Company Details
Table 114. Qiagen Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 115. Qiagen Recent Development
Table 116. Genomic Health Company Details
Table 117. Genomic Health Business Overview
Table 118. Genomic Health Product
Table 119. Genomic Health Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 120. Genomic Health Recent Development
Table 121. Myriad Genetics Company Details
Table 122. Myriad Genetics Business Overview
Table 123. Myriad Genetics Product
Table 124. Myriad Genetics Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 125. Myriad Genetics Recent Development
Table 126. Advanced Cell Diagnostics Company Details
Table 127. Advanced Cell Diagnostics Business Overview
Table 128. Advanced Cell Diagnostics Product
Table 129. Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 130. Advanced Cell Diagnostics Recent Development
Table 131. Danaher Company Details
Table 132. Danaher Business Overview
Table 133. Danaher Product
Table 134. Danaher Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 135. Danaher Recent Development
Table 136. Applied Proteomics Company Details
Table 137. Applied Proteomics Business Overview
Table 138. Applied Proteomics Product
Table 139. Applied Proteomics Revenue in Companion Diagnostics Business (2015-2020) (Million US$)
Table 140. Applied Proteomics Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Companion Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Companion Diagnostics Report Years Considered
Figure 12. Global Companion Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Companion Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Companion Diagnostics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Companion Diagnostics Market Share by Players in 2019
Figure 17. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostics Revenue in 2019
Figure 19. North America Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
デジタルコンパニオン診断の世界市場（～2026年） Market Analysis and Insights: Global Digital Companion Diagnostics Market The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Digital Companion Diagnostics Scope and Market Size Dig…- ポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）の世界市場（～2026年） Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics marke…
- 蛍光in situハイブリダイゼーションプローブの世界市場（～2026年） Market Analysis and Insights: Global Fluorescent in Situ Hybridization Probe Market The global Fluorescent in Situ Hybridization Probe market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fluorescent in Situ Hybridization P…
- RNA In Situハイブリダイゼーションの世界市場（～2026年） Market Analysis and Insights: Global RNA In Situ Hybridization Market The global RNA In Situ Hybridization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RNA In Situ Hybridization Scope and Market Size RNA In Situ Hyb…
- 腫瘍におけるコンパニオン診断検査の世界市場（～2026年） Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer. Market Analysis and Insights…